Poliovirus Receptor Antikörper (AA 314-342) (PE)
-
- Target Alle Poliovirus Receptor (PVR) Antikörper anzeigen
- Poliovirus Receptor (PVR)
-
Bindungsspezifität
- AA 314-342
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Poliovirus Receptor Antikörper ist konjugiert mit PE
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- This PVR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 314-342 amino acids from the C-terminal region of human PVR.
- Aufreinigung
- Affinity purified
- Isotyp
- IgG
- Top Product
- Discover our top product PVR Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, no preservatives added
- Konservierungsmittel
- Without preservative
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
- Haltbarkeit
- 6 months
-
- Target
- Poliovirus Receptor (PVR)
- Andere Bezeichnung
- PVR / CD155 (PVR Produkte)
- Synonyme
- PVR antikoerper, CD155 antikoerper, HVED antikoerper, NECL5 antikoerper, Necl-5 antikoerper, PVS antikoerper, TAGE4 antikoerper, 3830421F03Rik antikoerper, D7Ertd458e antikoerper, Taa1 antikoerper, Tage4 antikoerper, mE4 antikoerper, necl-5 antikoerper, poliovirus receptor antikoerper, PVR antikoerper, Pvr antikoerper
- Hintergrund
-
Name/Gene ID: PVR
Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4 - Gen-ID
- 5817
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interaktom
-